The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
As HIV drug resistance increases in low- and middle-income countries, getting people onto antiretroviral treatment means little in the long run if treatment programming is not also strengthened.
Testing for HIV is rising in the UK, but opportunities are being missed among some vulnerable groups.
South Africa’s national antiretroviral treatment programme has successfully reduced deaths and enabled people with HIV to maintain good health – but men are far less likely to benefit.
New research shows antiretroviral treatment radically reduces health inequalities – supporting arguments for scale-up of HIV treatment in low-resourced contexts.
The President’s Emergency Plan for AIDS Relief (PEPFAR) is to accelerate efforts in just 13 countries under its news strategy. But critics say this narrowed focus could lead to a resurgence of the HIV epidemic.
Untreated depression could seriously compromise treatment outcomes for people living with HIV, warn critics.
A BMJ international panel made up of women living with HIV, specialist doctors, and general practitioners recommends non-tenofovir based treatment regimes for pregnant women living with HIV.
Savings would be ‘small and transient’ – raising significant ethical and efficacy concerns about the benefit of US budget cuts for HIV programming abroad.
HIV programmes must develop strategies and allocate resources for people who enter the ‘failure care cascade’ – or risk jeopardising the important gains already made on HIV treatment.
Young adults represent a growing proportion of the number of people living with HIV in the USA, but they are at high-risk of disengaging from care when transitioning from paediatric to adult services.